J&J Unit Asks 3rd Circ. To Nix Cert. In Blood Test Antitrust Row

By Scott Flaherty (June 25, 2013, 5:19 PM EDT) -- A Johnson & Johnson unit told the Third Circuit on Monday that buyers of reagents used in blood tests did not meet the burden to secure class status in multidistrict litigation alleging the company conspired to fix prices on the reagents....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!